Clinical isolates and laboratory reference Candida species and strains have varying abilities to form biofilms

FEMS Yeast Research

Volumn 13, Issue 7, 2013, Pages 689-699

  Alnuaimi, Ali D ^a   O'Brien Simpson, Neil M ^a   Reynolds, Eric C ^a   Mccullough, Michael J ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Assays; Biofilm formation; Clinical; Laboratory

Indexed keywords

CRYSTAL VIOLET; TETRAZOLIUM;

ARTICLE; BIOFILM; BIOMASS; CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA; CELL COUNT; COLONY FORMING UNIT; FUNGAL STRAIN; FUNGUS GROWTH; GENOTYPE; NONHUMAN;

CANDIDA; CANDIDA ALBICANS; CANDIDA DUBLINIENSIS; CANDIDA GLABRATA;

ASSAYS; BIOFILM FORMATION; CLINICAL; LABORATORY;

BIOFILMS; CANDIDA; CANDIDIASIS; HUMANS; LABORATORIES; MICROBIOLOGICAL TECHNIQUES; STAINING AND LABELING;

EID: 84886089268     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/1567-1364.12068     Document Type: Article

References (37)

1. Adam B, Baillie GS & Douglas LJ (2002) Mixed species biofilms of Candida albicans and Staphylococcus epidermidis. J Med Microbiol 51: 344-349.
2. Andes D, Nett J, Oschel P, Albrecht R, Marchillo K & Pitula A (2004) Development and characterization of an in vivo central venous catheter Candida albicans biofilm model. Infect Immun 72: 6023-6031.
3. Arendorf TM & Walker DM (1980) The prevalence and intra-oral distribution of Candida albicans in man. Arch Oral Biol 25: 1-10.
4. Baillie GS & Douglas LJ (2000) Matrix polymers of Candida biofilms and their possible role in biofilm resistance to antifungal agents. J Antimicrob Chemother 46: 397-403.
5. Calderone RA & Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
6. Chandra J, Kuhn DM, Mukherjee PK, Hoyer LL, McCormick T & Ghannoum MA (2001) Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J Bacteriol 183: 5385-5394.
7. Chandra J, Mukherjee PK & Ghannoum MA (2008) In vitro growth and analysis of Candida biofilms. Nat Protoc 3: 1909-1924.
8. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR & Lappin-Scott HM (1995) Microbial biofilms. Annu Rev Microbiol 49: 711-745.
9. Davey ME & O'Toole GA (2000) Microbial biofilms: from ecology to molecular genetics. Microbiol Mol Biol Rev 64: 847-867.
10. Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33: 1387-1392.
11. Donlan RM & Costerton JW (2002) Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 15: 167-193.
12. Douglas LJ (2003) Candida biofilms and their role in infection. Trends Microbiol 11: 30-36.
13. Franzot SP, Mukherjee J, Cherniak R, Chen LC, Hamdan JS & Casadevall A (1998) Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes. Infect Immun 66: 89-97.
14. Fries BC & Casadevall A (1998) Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. J Infect Dis 178: 1761-1766.
15. Henriques M, Azeredo J & Oliveira R (2006) Candida albicans and Candida dubliniensis: comparison of biofilm formation in terms of biomass and activity. Br J Biomed Sci 63: 5-11.
16. Jin Y, Yip HK, Samaranayake YH, Yau JY & Samaranayake LP (2003) Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection. J Clin Microbiol 41: 2961-2967.
17. Jin Y, Samaranayake LP, Samaranayake Y & Yip HK (2004) Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars. Arch Oral Biol 49: 789-798.
18. Khun DM, George T, Chandra J, Mukherrjee PK & Ghannoum MA (2002) Antifungal susceptibility of Candida biofilm: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 46: 1773-1780.
19. Kuhn DM, Chandra J, Mukherjee PK & Ghannoum MA (2002) Comparison of biofilms formed by Candida albicans and Candida parapsilosis on bioprosthetic surfaces. Infect Immun 70: 878-888.
20. Kuhn DM, Balkis M, Chandra J, Mukherjee PK & Ghannoum MA (2003) Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J Clin Microbiol 41: 506-508.
21. Mah TF & O'Toole GA (2001) Mechanisms of biofilm resistance to antimicrobial agents. Trends Microbiol 9: 34-39.
22. McCullough MJ, Clemons KV & Stevens DA (1999) Molecular and phenotypic characterization of genotypic Candida albicans subgroups and comparison with Candida dubliniensis and Candida stellatoidea. J Clin Microbiol 37: 417-421.
23. O'Toole GA, Kaplan HB & Kolter R (2000) Biofilm formation as microbial development. Annu Rev Microbiol 54: 49-79.
24. Peeters E, Nelis HJ & Coenye T (2008) Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates. J Microbiol Methods 72: 157-165.
25. Ramage G, Vande Walle K, Wickes BL & Lopez-Ribot JL (2001) Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother 45: 2475-2479.
26. Ramage G, Coco B, Sherry L, Bagg J & Lappin DF (2012) In vitro Candida albicans biofilm induced proteinase activity and SAP8 expression correlates with in vivo denture stomatitis severity. Mycopathologia 174: 11-19.
27. Samaranayake LP & MacFarlane TW (1990) Oral Candidosis. Wright-Butterworth, London.
28. Samaranayake LP, Fidel PL, Naglik JR, Sweet SP, Teanpaisan R, Coogan MM, Blignaut E & Wanzala P (2002) Fungal infections associated with HIV infection. Oral Dis 8: 151-160.
29. Sardi JC, Duque C, Höfling JF & Gonçalves RB (2012) Genetic and phenotypic evaluation of Candida albicans strains isolated from subgingival biofilm of diabetic patients with chronic periodontitis. Med Mycol 50: 467-475.
30. Selmecki A, Forche A & Berman J (2010) Genomic plasticity of the human fungal pathogen Candida albicans. Eukaryot Cell 9: 991-1008.
31. Seneviratne CJ, Jin LJ, Samaranayake YH & Samaranayake LP (2008) Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms. Antimicrob Agents Chemother 52: 3259-3266.
32. Silva S, Henriques M, Martins A, Oliveira R, Williams D & Azeredo J (2009) Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition. Med Mycol 47: 681-689.
33. Silva S, Henriques M, Oliveira R, Williams D & Azeredo J (2010) In vitro biofilm activity of non-Candida albicans Candida species. Curr Microbiol 61: 534-540.
34. Tobudic S, Kratzer C, Lassnigg A, Willinger B, Graninger W & Presterl E (2011) Biofilm formation of Candida spp. isolates from patients at a cardiothoracic intensive care unit. Int J Artif Organs 34: 818-823.
35. Tumbarello M, Posteraro B, Trecarichi EM et al. (2007) Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol 45: 1843-1850.
36. Tunnet MM, Gorman SP & Patrick S (1996) Infection associated with medical devices. Rev Med Microbiol 7: 195-205.
37. Zeng X, Xiong C, Wang Z, Jiang L, Hou X, Shen J, Zhou M & Chen Q (2008) Genotypic profiles and virulence attributes of Candida albicans isolates from patients with oral lichen planus. APMIS 116: 284-291.